Evidence map›Paper›PMID 36883820›Full record

ReviewJournal of clinical microbiology2023

Review of Clinical and Laboratory Diagnostics for Coccidioidomycosis.

Ian H McHardy, Bridget Barker, George R Thompson

Open access · greenAbstract readReview
In one paragraph

Review in Journal of clinical microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Disseminated coccidioidomycosis in an immunocompetent traveler.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Valley Fever in Central California: Diagnosis is Not the Finish Line, the Real Gap is Longitudinal Care.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Overview of the Current Challenges in Pulmonary Coccidioidomycosis.Journal of fungi (Basel, Switzerland) · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Ian H McHardyScripps Medical Laboratory, Scripps Health, San Diego, California, USA.ORCID 0000-0002-2121-5460
Bridget BarkerDepartment of Biological Sciences, Northern Arizona University, Flagstaff, Arizona, USA.ORCID 0000-0002-3439-4517
George R ThompsonDepartment of Internal Medicine, Division of Infectious Diseases, University of California, Davis Medical Center, Sacramento, California, USA.ORCID 0000-0001-8518-5750
Northern Arizona University · USScripps Health · USUniversity of California Davis Medical Center · US

Funding

Virulence gene discovery in CoccidioidesU19AI166798 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Satya Dandekar · 2022 to 2026
$10.5M
NIAID NIH HHS U19 AI166798
6 · The paper itself

Abstract

Coccidioidomycosis is a fungal disease associated with soil exposure that frequently goes undiagnosed due at least in part to its nonspecific presentation and the lack of clinical suspicion by health care providers. Currently available diagnostics for coccidioidomycosis offer qualitative results that can suffer from low specificity, while semiquantitative assays are labor-intensive and complex and can require multiple days to complete. Furthermore, significant confusion exists regarding the optimal diagnostic algorithms and appropriate usage of available diagnostic tests. This review aims to inform clinical laboratorians and treating clinicians about the current diagnostic landscape, appropriate diagnostic strategies, and future diagnostic directions for coccidioidomycosis, which is expected to become more prevalent due to increased migration into areas of endemicity and climate changes.

Indexed as

CoccidioidomycosisAntibodies, FungalBiological AssayCoccidioidesHumansAntibodies, FungalantibodyantigenCoccidioidescoccidioidomycosiscomplement fixationdiagnosticsenzyme immunoassayfungusimmunodiffusionserologyvalley fever

Identifiers

PMID36883820
PMCPMC10204634
OpenAlexW4323535623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.